Skip to main content

Table 2 Genotypic data from participants with HIV RNA1000 copies/mL (2008-09) stratified by HIV RNA (2012-13)

From: Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up

 

Total(N = 35)

HIV-1 RNA<400 copies/mL(N = 25)

HIV-1 RNA <400 copies/mL(N = 10)

Subtypes

   

A

12 (35%)

8 (32%)

4 (40%)

B

1 (3%)

1 (4%)

0

C

5 (14%)

4 (16%)

1 (10%)

D

11 (31%)

8 (32%)

3 (30%)

Recombinant (A/C; A/D; D/C; K/C)

6 (17%)

4 (16%)

2 (20%)

NRTI

   

M184V

31 (89%)

22 (88%)

9 (90%)

TAMs

   

0 TAMs

18 (51%)

15 (60%)

3 (30%)

1 TAM

10 (29%)

6 (24%)

4 (40%)

≥ 2 TAMs

7 (20%)

4 (16%)

3 (30%)

NNRTI

   

K103N

14 (40%)

9 (36%)

5 (50%)

Y181C

8 (23%)

5 (20%)

3 (30%)